163 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 4 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x RNA tissue categoryi x
MMP11Matrix metallopeptidase 11Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Group enriched
MMP12Matrix metallopeptidase 12Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enhanced
MMP13Matrix metallopeptidase 13Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
MMP14Matrix metallopeptidase 14Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Intermediate filaments
Cytosol
Mixed
MMP17Matrix metallopeptidase 17Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
MMP19Matrix metallopeptidase 19Disease related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Endoplasmic reticulum
Vesicles
Tissue enhanced
MMP2Matrix metallopeptidase 2Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Vesicles
Cytosol
Tissue enhanced
MMP20Matrix metallopeptidase 20Disease related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
MMP21Matrix metallopeptidase 21Disease related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
MMP25Matrix metallopeptidase 25Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
MMP26Matrix metallopeptidase 26Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
MMP27Matrix metallopeptidase 27Enzymes
FDA approved drug targets
Predicted secreted proteins
Group enriched
MMP28Matrix metallopeptidase 28Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
MMP3Matrix metallopeptidase 3Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
VesiclesTissue enhanced
MMP7Matrix metallopeptidase 7Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Nucleoplasm
Vesicles
Tissue enhanced
MMP8Matrix metallopeptidase 8Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
MMP9Matrix metallopeptidase 9Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
CytosolTissue enhanced
MR1Major histocompatibility complex, class I-relatedFDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Plasma membraneMixed
MTTPMicrosomal triglyceride transfer proteinDisease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
CytosolGroup enriched
PCSK9Proprotein convertase subtilisin/kexin type 9Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
PDE7APhosphodiesterase 7AEnzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
PDGFRAPlatelet derived growth factor receptor alphaCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Nucleus
Plasma membrane
Cell Junctions
Expressed in all
PDGFRBPlatelet derived growth factor receptor betaCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Golgi apparatus
Vesicles
Mixed
PGFPlacental growth factorCancer-related genes
Candidate cardiovascular disease genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
RAS pathway related proteins
Nucleoplasm
Mitochondria
Cytosol
Tissue enhanced
PLA2G1BPhospholipase A2 group IBCandidate cardiovascular disease genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
RAS pathway related proteins
CytosolTissue enriched
PLA2G2APhospholipase A2 group IIAEnzymes
FDA approved drug targets
Predicted secreted proteins
RAS pathway related proteins
Nucleus
Nucleoli
Tissue enhanced
PLATPlasminogen activator, tissue typeCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Actin filamentsTissue enriched
PLAUPlasminogen activator, urokinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
PLAURPlasminogen activator, urokinase receptorCancer-related genes
CD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membraneExpressed in all
PLGPlasminogenCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
VesiclesTissue enriched
PNLIPPancreatic lipaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
PNPPurine nucleoside phosphorylaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
CytosolExpressed in all
PRLRProlactin receptorDisease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
PROCProtein C, inactivator of coagulation factors Va and VIIIaCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
PROS1Protein S (alpha)Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
PTGIRProstaglandin I2 (prostacyclin) receptor (IP)FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
PTGS1Prostaglandin-endoperoxide synthase 1Cancer-related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Golgi apparatus
Vesicles
Tissue enhanced
PTGS2Prostaglandin-endoperoxide synthase 2Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Endoplasmic reticulumTissue enhanced
QPRTQuinolinate phosphoribosyltransferaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
RAMP2Receptor activity modifying protein 2FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
VesiclesMixed
RENReninCandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
RETRet proto-oncogeneCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Vesicles
Plasma membrane
Cytosol
Tissue enriched
RPL3Ribosomal protein L3FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Ribosomal proteins
Nucleoli
Cytosol
Expressed in all
SCN1BSodium voltage-gated channel beta subunit 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
SCN3BSodium voltage-gated channel beta subunit 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Intermediate filaments
Cytosol
Tissue enriched
SDHDSuccinate dehydrogenase complex subunit DCancer-related genes
Citric acid cycle related proteins
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
SERPINB2Serpin family B member 2Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Group enriched
SERPINC1Serpin family C member 1Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
SERPIND1Serpin family D member 1Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
VesiclesTissue enriched
SERPINE1Serpin family E member 1Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
CytosolTissue enhanced
« prev | Page of 4 | next »